Retroperitoneal Neoplasms

Phase 2 trials (1)

• niraparib

Phase 1 trials (6)

• prednisone
• doxorubicin
• nivolumab
• vincristine
• cyclophosphamide
• cisplatin

Organization Involved with Phase 2 Indications (1)

• The University of Texas, Dallas

Organization Involved with Phase 1 Indications (4)

• Bristol-Myers Squibb
• National Cancer Institute (NCI)
• University of Texas at Houston
• OHSU Knight Cancer Institute